Does Prestroke Antiplatelet Therapy Increase the Risk of Symptomatic Intracranial Hemorrhage in Patients Receiving Tissue Plasminogen Activator for Acute Ischemic Stroke?

Clark G. Owyang; Cappi Lay

doi:10.1016/j.annemergmed.2017.03.013

Does Prestroke Antiplatelet Therapy Increase the Risk of Symptomatic Intracranial Hemorrhage in Patients Receiving Tissue Plasminogen Activator for Acute Ischemic Stroke?

Clark G. Owyang, Cappi Lay

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	416-418
Number of pages	3
Journal	Annals of Emergency Medicine
Volume	71
Issue number	3
DOIs	https://doi.org/10.1016/j.annemergmed.2017.03.013
State	Published - Mar 2018

Access to Document

10.1016/j.annemergmed.2017.03.013

Cite this

@article{f11640bc8a7b4c1db9b719bc08f8bcaa,

title = "Does Prestroke Antiplatelet Therapy Increase the Risk of Symptomatic Intracranial Hemorrhage in Patients Receiving Tissue Plasminogen Activator for Acute Ischemic Stroke?",

author = "Owyang, {Clark G.} and Cappi Lay",

year = "2018",

month = mar,

doi = "10.1016/j.annemergmed.2017.03.013",

language = "English",

volume = "71",

pages = "416--418",

journal = "Annals of Emergency Medicine",

issn = "0196-0644",